Precision medicine breakthroughs rely on uncovering and exploring novel biomarkers and mechanisms of action. Yet the reality is many patients aren’t getting tested for established biomarkers—let alone emerging research candidates. In this webinar, we discuss the limitations of standard of care data and share proven strategies for delivering research-ready samples enriched with meaningful data.